Investing.com - Senti Biosciences (NASDAQ: SNTI) reported third quarter EPS of $-0.8300, $0.39 worse than the analyst estimate of $-0.4420. Revenue for the quarter came in at $338K versus the consensus estimate of $668.5K.
Senti Biosciences's stock price closed at $0.4300. It is down -34.2800% in the last 3 months and down -82.4300% in the last 12 months.
Senti Biosciences saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Senti Biosciences's stock price’s past reactions to earnings here.
According to InvestingPro, Senti Biosciences's Financial Health score is "fair performance".
Check out Senti Biosciences's recent earnings performance, and Senti Biosciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar